Page 25 - Noble-Virtual-Healthcare-2024

Electromed, Inc.

SELECTED FINANCIAL ITEMS ELMD

(in millions of USD)
CQ1 '23 CQ2 '23 CQ3 '23 CQ4 '23 LTM
Income Statement Key Items
Total Revenue 12.07 13.61 12.32 13.69 51.69
Gross Profit 9.06 10.45 9.50 10.55 39.55
Gross Margin 75% 77% 77% 77% 77%
EBIT 1.20 1.49 0.14 2.26 5.10
EBIT Margin 10% 11% 1% 17% 10%
Net Income to Common Shareholders 1.08 1.03 0.16 1.67 3.94
Net Margin 9% 8% 1% 12% 8%

Balance Sheet Key Items
Total Assets 42.84 45.81 44.07 46.96 46.96
Cash & Short Term Investments 6.78 7.37 7.02 10.43 10.43
% of Assets 16% 16% 16% 22% 22%
Current Assets -Total 35.17 37.79 36.20 39.27 39.27
% of Assets 82% 82% 82% 84% 84%
Total Liabilities 6.45 8.14 5.84 6.62 6.62
% of Assets 15% 18% 13% 14% 14%
Current Liabilities - Total 6.42 8.05 5.78 6.57 6.57
% of Assets 15% 18% 13% 14% 14%
Long Term Debt NA NA NA NA NA
% of Assets NM NM NM NM NM
Total Equity 36.39 37.67 38.22 40.34 40.34
% of Assets 85% 82% 87% 86% 86%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities 0.65 1.00 (0.24) 3.47 4.87
Net Cash Flow - Investing (0.56) (0.44) (0.13) (0.09) (1.22)
Net Cash Flow - Financing (0.22) 0.04 0.03 0.03 (0.13)

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Nineteenth Annual Small & Microcap Investor Conference